London-based private equity firm Alchemy Partners has agreed to sell the 58 percent stake in outsourced office provider Regus that it acquired three years ago back to the company.
Â
Regus said that it has paid Alchemy £88 million (€127 million; $157 million) to acquire the 58 percent stake in the UK arm of the business, Regus UK, that it did not own.
Â
A spokesman for Alchemy said that the firm had made a £35 million profit on the disposal, which represented an exit multiple of 12.2 times Regus UK’s 2005 EBITDA.
Â
Alchemy paid £57 million to acquire the stake in December 2002 at a time when Regus was facing the prospect of defaulting on debt payments after failing to secure additional financing from its banks.
Â
The buy-back is being funded by a £50 million loan from the Royal Bank of Scotland, Lloyds TSB and National Australia Bank, as well as a drawdown of £38 million from a £100 million revolving credit facility provided by the banks in mid-March.
Â
Regus UK is a provider of services offices and business centres across the UK comprising 91 business centres and 25,000 workstations. The company currently has £21.8 million in net cash and reported £8.6 million of EBITDA and a profit after tax of £0.5 million on sales of £161.4 million.
Â
Alchemy has been in acquisitive mode in recent months. In March of this year, the firm had a 270.5 pence per share offer for Parkdean Holiday accepted by the UK holiday parks operator’s board. The offer, which valued the business at approximately £135.3 million, had received acceptances from 64.6 percent of Parkdean shareholders at the beginning of this week.
Â
In January, Alchemy completed the £42.5 million acquisition of AIM-listed Inventive Leisure, which operates a chain of vodka bars under the Revolution brand. The purchase closely followed the acquisition of 178 pubs from Spirit Group for £177 million in September 2005.
Alchemy sells back Regus UK holding
UK serviced office provider Regus has bought back a majority stake in its Regus UK business three years after selling it to UK private equity firm Alchemy Partners.